Back to Search
Start Over
Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose Administration.
- Source :
-
Clinical Therapeutics . Feb2021, Vol. 43 Issue 2, p396-409. 14p. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 01492918
- Volume :
- 43
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Clinical Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 149593071
- Full Text :
- https://doi.org/10.1016/j.clinthera.2020.12.012